you are in demo mode.    to view your own genetic profile, order your scan now.

Site search

  • your results
  • background
  • risk and prevention
  • scientific details
  • research
  • discussion
  • >>

Basal Cell Carcinoma

Basal cell carcinoma is the most commonly occurring cancer in humans.

Please select a gender or population for your results.

This disease has different risk results depending on population or gender. Below you can select the ones you belong to.

Ethnicity:  European ancestry

Gender:   

Results can vary according to population and/or gender. Results currently based on:

European ancestry

Trait_world_map

Male

Trait_male_female

change


Bcc
According to the selected literature, the relative genetic risk calculated from your genotype for males of European ancestry is 1.25. This corresponds to a 43.8% lifetime risk of developing basal cell carcinoma, which is 25% greater than for males of European ancestry in general (source) . Note that these calculations may not include all risk factors.
The lifetime risk of your type
It is estimated that 44 of every 100 males of European ancestry with your genotype variants develop this disease in their lifetime.
Bcc
The average lifetime risk
On average, about 35 of every 100 males of European ancestry develop this disease in their lifetime.
Bcc

Please note

As ultraviolet (UV) radiation exposure is such an important environmental risk factor for basal cell carcinoma, it may be assumed that the lifetime risk of developing basal cell carcinoma will vary according to the magnitude of UV exposure where you live. For that reason, your lifetime risk may be higher or lower than that reported here. Unfortunately, the scientific literature does not yet provide reliable information about the differences in the lifetime risk of basal cell carcinoma for people in different places around the world.

Consult with our experts

Need something clarified? If so, please feel free to contact our experts. Based on the nature of your questions, we may refer you to a genetic counselor.

ask a question about Basal Cell Carcinoma

Keep in mind

These are the results of calculations comparing your genetic sequence to sequence of participants in studies published in the world literature on genetic risk for this disease. Read more about how deCODEme calculates risks.

This test was developed and its performance characteristics determined by the deCODE genetics Diagnostic Laboratory. It has not been cleared or approved by the U. S. Food and Drug Administration (FDA).